Soona Shin

Soona Shin has led transformative projects in the field of liver cancer research, particularly focusing on hepatocellular carcinoma and pediatric hepatocellular carcinoma. As an Associate Professor-Affiliate in the Department of Surgery at the University of Cincinnati College of Medicine, Dr. Shin brings a wealth of knowledge and experience to her role. She earned her PhD in Pharmacology and Molecular Sciences from Johns Hopkins University, followed by postdoctoral studies in Genetics at the University of Pennsylvania, which have equipped her with a robust foundation in both the molecular and genetic aspects of liver diseases. Dr. Shin's research interests are deeply rooted in understanding the complex mechanisms of liver cancer and exploring innovative therapeutic strategies. Her work on liver regeneration is particularly noteworthy, as it holds promise for improving treatment outcomes for patients with liver cancer. Through her research, Dr. Shin aims to uncover new insights into the pathogenesis of liver diseases, ultimately contributing to the development of more effective and targeted therapies. Her extensive portfolio of peer-reviewed publications highlights her commitment to advancing the field of hepatocellular carcinoma research. Dr. Shin's studies have not only enhanced the scientific community's understanding of disease mechanisms but have also paved the way for potential breakthroughs in treatment approaches. Her contributions are recognized both nationally and internationally, reflecting her status as a leading expert in her field. In addition to her research endeavors, Dr. Shin is dedicated to mentoring the next generation of scientists and clinicians. She actively engages with students and colleagues, fostering an environment of collaboration and innovation. Her passion for education and research is evident in her commitment to guiding young researchers in their pursuit of scientific excellence. Dr. Shin's work continues to have a significant impact on the field of liver cancer research, and her ongoing projects promise to further our understanding of this challenging disease. Her dedication to improving patient outcomes through scientific discovery underscores her role as a pivotal figure in the medical research community.